Inuvo Inc (AMEX:INUV) does about 1.80M shares in volume on a normal day but saw 3811407 shares change hands in the recent trading day. The company now has a market cap of 74.48M USD. Its current market price is $0.53, marking an increase of 19.10% compared to the previous close of $0.45. The 52 week high reached by this stock is $0.79 whilst the lowest price level in 52 weeks is $0.19.
Inuvo Inc (INUV) has a 20-day trading average at $0.5171 and the current price is -32.91% off the 52-week high compared with 179.00% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3764 and its 200-day simple moving average is $0.3061. If we look at the stock’s price movements over the week, volatility stands at 13.72%, which increases to 18.09% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 55.62 to suggest the stock is neutral.
The consensus objective for the share price is $0.95, suggesting that the stock has a potential upside of 44.21% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 28, 2020 when Alliance Global Partners initiated the stock to “Buy” and issued a price target of $2.25. ROTH Capital initiated its price target at $4.50.
The current price level is 2.52%, 40.84%, and 73.20% away from its SMA20, SMA50, and SMA200 respectively, with the INUV price moving below the 50-day SMA on current market day. Inuvo Inc (INUV) stock is up 6.08% over the week and 38.12% over the past month. Its price is -17.99% year-to-date and 32.49% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0.0 and -0.03 for whole year. Expected sales for next quarter are $19.13M, which analysts say will come at $82.9M for the current fiscal year and next year at $106.05M. In addition, estimates put the company’s current quarterly revenue at an average of $25.28M.
To reach the target analysts have set, the stock logically needs to grow 44.21 percent from here.
Outstanding shares total 140.47M with insiders holding 14.38% of the shares and institutional holders owning 19.47% of the company’s common stock. The company has a return on investment of -62.87% and return on equity of -53.11%. The forward price to earnings ratio is 4077.69. The beta has a value of 0.92. Price to book ratio is 6.00 and price to sales ratio is 0.95.